Zobrazeno 1 - 10
of 55
pro vyhledávání: '"59"'
Autor:
Grace Lin, Jae K. Oh, Sherine E. Gabriel, Hector R. Villarraga, Nowell M. Fine, Cynthia S. Crowson
Publikováno v:
Annals of the Rheumatic Diseases. 73:1833-1839
Patients with rheumatoid arthritis (RA) are at increased risk for cardiovascular disease (CVD), although strategies to detect subclinical CVD are poorly characterised. The purpose of this study was to assess myocardial function by speckle-tracking ec
Publikováno v:
Annals of the Rheumatic Diseases, 59, 914-918
Annals of the Rheumatic Diseases, 59, pp. 914-918
Annals of the Rheumatic Diseases, 59, pp. 914-918
Patients with yersinia triggered reactive arthritis were double blind randomly allocated to receive treatment with ciprofloxacin 500 mg twice daily orally or placebo during three months. The diagnosis was made by serology (specific IgA and IgG antibo
Autor:
A. Prins, A Z Ginai-Karamat, Arthur M. Bohnen, S.M.A. Bierma-Zeinstra, J S Laméris, Jan A N Verhaar
Publikováno v:
Annals of the Rheumatic Diseases, 59, 178-182. BMJ Publishing Group
Annals of the rheumatic diseases, 59(3), 178-182. BMJ Publishing Group
Annals of the rheumatic diseases, 59(3), 178-182. BMJ Publishing Group
OBJECTIVE: To study the prevalence of ultrasonic hip joint effusion and its relation with clinical, radiological and laboratory (ESR) findings in adults with hip pain. METHODS: Patients (n = 224) aged 50 years or older with hip pain, referred by the
Autor:
Neil Basu, Gary J. Macfarlane, John McBeth, Paul McNamee, Huey Chong, Philip C Hannaford, Neil W. Scott, Gareth T. Jones, Gordon Prescott, Marcus Beasley, Phil Keeley, Karina Lovell
Publikováno v:
Annals of the Rheumatic Diseases
ObjectiveCognitive–behavioural therapy (CBT) has been shown to be effective in the management of chronic widespread pain (CWP); we now test whether it can prevent onset among adults at high risk.MethodsA population-based randomised controlled preve
Autor:
L. B. A. Van De Putte, E.J.A. Kroot, M.A. van 't Hof, M.A. van Leeuwen, M.L.L. Prevoo, M. H. Van Rijswijk, P.L.C.M. van Riel
Publikováno v:
Annals of the Rheumatic Diseases, 59, 954-958
Annals of the Rheumatic Diseases, 59, pp. 954-958
Annals of the Rheumatic Diseases, 59, pp. 954-958
OBJECTIVE—To investigate mortality, functional capacity, and prognostic factors for mortality in an inception cohort of patients with recently diagnosed RA followed up for up to 10 years. METHODS—The observed mortality of this inception cohort wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d77a685ea869e0b5af732dce17c74c
http://hdl.handle.net/2066/187969
http://hdl.handle.net/2066/187969
Autor:
PP Tak
Publikováno v:
Annals of the rheumatic diseases, 59(12), 929-930. BMJ Publishing Group
Annals of the Rheumatic Diseases, 59, 929-930. BMJ Publishing Group
Annals of the Rheumatic Diseases, 59, 929-930. BMJ Publishing Group
To compare the macroscopic and microscopic characteristics of synovial tissue in rheumatoid arthritis (RA), spondyloarthropathy (SpA), and osteoarthritis (OA) after exclusion of possible biases induced by disease duration or activity, or both.Synovia
Autor:
Ellen M. Gravallese, Yuqing Zhang, Jeffrey A. Sparks, Naomi Serling-Boyd, April Jorge, Tiffany Y-T Hsu, Zachary S. Wallace, Kristin M. D’Silva, Hyon K. Choi, Rachel Wallwork, Xiaoqing Fu
Publikováno v:
Annals of the Rheumatic Diseases
ObjectiveIn earlier studies, patients with rheumatic and musculoskeletal disease (RMD) who got infected with COVID-19 had a higher risk of mechanical ventilation than comparators. We sought to determine COVID-19 outcomes among patients with RMD 6 mon
Autor:
Paul A. Monach, Shunsuke Furuta, Nader Khalidi, Carol A. Langford, Robert Spiera, Vladimir Tesar, Charles D. Pusey, Brian Camilleri, Caroline Wroe, Raashid Luqmani, Marianna Nodale, Carole McAlear, Patrick H. Nachman, Annette Bruchfeld, Chee Kay Cheung, Yoshinori Komagata, Curry L. Koening, Peter A. Merkel, Giles Walters, Peter Lanyon, Rennie L. Rhee, Hirofumi Makino, David Jayne, Tim Doulton, Fiona A Pearce, Toshiko Ito-Ihara, Dwarakanathan Ranganathan, Antoine G. Sreih, Kim Mynard, J. Andrews, Michael H. Weisman, Lorraine Harper, Rona M Smith, Reem Al-Jayyousi, Ulrich Specks, Larry W. Moreland, Lindsy J. Forbess, Shouichi Fujimoto, Simon Bond, Chen Au Peh, Ora Gewurz-Singer, Vimal K. Derebail, Rainer Klocke, Simon Carette, Rachel B Jones, Christian Pagnoux
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesEvaluation of rituximab and glucocorticoids as therapy to induce remission after relapse in ANCA-associated vasculitis (AAV) in a prospective observational cohort of patients enrolled into the induction phase of the RITAZAREM trial.MethodsP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567e22e9ed0f5813a3c99113e2e07994
Publikováno v:
Annals of the Rheumatic Diseases. 76:179-185
ObjectiveTo establish reference intervals for osteoarthritis (OA)-related biomarkers used in the Foundation for the National Institutes of Health (FNIH) OA Biomarkers Consortium Project.MethodsA total of 129 ‘multijoint controls’ were selected fr
Autor:
Bart J F van den Bemt, Alfons A den Broeder, Ronald F van Vollenhoven, Aatke van der Maas, Noortje van Herwaarden, Frank H J van den Hoogen, Johannes W. J. Bijlsma, Wietske Kievit
Publikováno v:
Annals of the Rheumatic Diseases, 75(11), 1939-1944. BMJ Publishing Group
Annals of the Rheumatic Diseases, 75, 11, pp. 1939-1944
Kievit, W, van Herwaarden, N, van den Hoogen, F H, van Vollenhoven, R F, Bijlsma, J W, van den Bemt, B J, van der Maas, A & den Broeder, A A 2016, ' Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care : analyses of the DRESS study ', Annals of the Rheumatic Diseases, vol. 75, no. 11, pp. 1939-1944 . https://doi.org/10.1136/annrheumdis-2015-208317
Annals of the Rheumatic Diseases, 75, 1939-1944
Annals of the rheumatic diseases, 75(11), 1939-1944. BMJ Publishing Group
Annals of the Rheumatic Diseases, 75, 11, pp. 1939-1944
Kievit, W, van Herwaarden, N, van den Hoogen, F H, van Vollenhoven, R F, Bijlsma, J W, van den Bemt, B J, van der Maas, A & den Broeder, A A 2016, ' Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care : analyses of the DRESS study ', Annals of the Rheumatic Diseases, vol. 75, no. 11, pp. 1939-1944 . https://doi.org/10.1136/annrheumdis-2015-208317
Annals of the Rheumatic Diseases, 75, 1939-1944
Annals of the rheumatic diseases, 75(11), 1939-1944. BMJ Publishing Group
BackgroundA disease activity-guided dose optimisation strategy of adalimumab or etanercept (TNFi (tumour necrosis factor inhibitors)) has shown to be non-inferior in maintaining disease control in patients with rheumatoid arthritis (RA) compared with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c25698f055dfcd8cea2c0e89b62dc587
https://cris.maastrichtuniversity.nl/en/publications/5a8a03d1-f3ed-411d-8cfa-3cb7b5bd2771
https://cris.maastrichtuniversity.nl/en/publications/5a8a03d1-f3ed-411d-8cfa-3cb7b5bd2771